Safeguarding public health has long been HKUMed’s core mission, from the 1894 Taipingshan plague to COVID-19. Our health care professionals and scientists have been at the forefront in the battle against COVID-19 since the very beginning of the pandemic. Now, we are supporting the most important phase of pandemic control by operating one of the designated community vaccination centres.

In so doing, we will also be carrying out lifesaving research into further ensuring the safety and effectiveness of vaccines, to give added protection for those who choose to enrol in our research programmes and more broadly to advance the science of vaccinology against COVID-19.

We will be responsible for a Community Vaccination Centre where we will administer the COVID-19 mRNA Vaccine: Comirnaty (BNT 162b2) from Fosun Pharma/BioNTech.

At the same time, we will be recruiting volunteers for vaccination research studies that will produce new knowledge for the next stage of COVID-19 control.



我們將負責營運一所社區疫苗接種中心,提供由復星醫藥與德國藥廠BioNTech共同研發的信使核糖核酸新冠疫苗「復必泰」(BNT 162b2)